Compositional modification of nascent in vitro dental plaques by human host-defence peptides

FEMS Immunology and Medical Microbiology

Volumn 64, Issue 3, 2012, Pages 374-381

  Madhwani, Tejal ^a   McBain, Andrew J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Aggregation; DGGE; Host defence peptides; Hydroxyapatite disc microcosms

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CELL PROTEIN; DEFENSIN; HISTATIN; HISTATIN 5; HYDROXYAPATITE; NEUTROPHIL PROTEIN; RNA 16S; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COUNT; BACTERIAL VIABILITY; CELL CULTURE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; FLUORESCENCE MICROSCOPY; GRAM NEGATIVE ANAEROBIC BACTERIA; HOST RESISTANCE; HUMAN; IN VITRO STUDY; LACTOBACILLUS; MOUTH FLORA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; TOOTH PLAQUE;

ALPHA-DEFENSINS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BETA-DEFENSINS; CELL AGGREGATION; DENTAL PLAQUE; HISTATINS; HUMANS; MICROBIAL VIABILITY; MICROSCOPY, FLUORESCENCE; RNA, RIBOSOMAL, 16S; SALIVARY PROTEINS AND PEPTIDES;

EID: 84858157300     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00922.x     Document Type: Article

References (47)

1. Boman HG (2000) Innate immunity and the normal microflora. Immunol Rev 173: 5-16.
2. Bowden GH & Hamilton IR (1989) Competition between Streptococcus mutans and Lactobacillus casei in mixed continuous culture. Oral Microbiol Immunol 4: 57-64.
3. Cabras T, Pisano E, Mastinu A, Denotti G, Pusceddu PP, Inzitari R, Fanali C, Nemolato S, Castagnola M & Messana I (2010) Alterations of the salivary secretory peptidome profile in children affected by type 1 diabetes. Mol Cell Proteomics 9: 2099-2108.
4. Castagnola M, Congiu D, Denotti G et al. (2001) Determination of the human salivary peptides histatins 1, 3, 5 and statherin by high-performance liquid chromatography and by diode-array detection. J Chromatogr B Biomed Sci Appl 751: 153-160.
5. Dale BA & Fredericks LP (2005) Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol 7: 119-133.
6. Dale BA, Kimball JR, Krisanaprakornkit S et al. (2001) Localized antimicrobial peptide expression in human gingiva. J Periodontal Res 36: 285-294.
7. Dimond G, Beckloff N, Weinberg A & Kisich KO (2009) The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 15: 2377-2392.
8. Dommisch H, Vorderwülbecke S, Eberhard J, Steglich M & Jepsen S (2009) SELDI-TOF-MS of gingival crevicular fluid-a methodological approach. Arch Oral Biol 54: 803-809.
9. Ganz T, Metcalf JA, Gallin JI, Boxer LA & Lehrer RI (1988) Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest 82: 552-556.
10. Garcia JR, Jaumann F, Schulz S et al. (2001) Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res 306: 257-264.
11. Ge Y, MacDonald D, Henry MM et al. (1999) In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers. Diagn Microbiol Infect Dis 35: 45-53.
12. Goebel C, Mackay LG, Vickers ER & Mather LE (2000) Determination of deafensin HNP-1, HNP-2, and HNP-3 in human saliva by using LC/MS. Peptides 21: 757-765.
13. Gordon YJ, Romanowski EG & McDermott AM (2005) A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res 30: 505-515.
14. Gorr SU & Abdolhosseini M (2011) Antimicrobial peptides and periodontal disease. J Clin Periodontol 38(Suppl 11): 126-141.
15. Guthmiller JM, Vargas KG, Srikantha R, Schomberg LL, Weistroffer PL, McCray PB & Tack BF (2001) Susceptibilities of oral bacteria and yeast to mammalian cathelicidins. Antimicrob Agents Chemother 45: 3216-3219.
16. Hancock REW & Devine DA (2004) Mammalian Host Defense Peptides: "Antimicrobial" or "Host Defense" Peptides. Cambridge University Press, Cambridge.
17. Harder J, Bartels J, Christophers E & Schroder JM (2001) Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276: 5707-5713.
18. Hardt M, Thomas LR, Dixon SE et al. (2005) Toward defining the human parotid gland salivary proteome and peptidome: identification and characterization using 2D SDS-PAGE, ultrafiltration, HPLC, and mass spectrometry. Biochemistry 44: 2885-2899.
19. Hoover DM, Rajashankar KR, Blumenthal R, Puri A, Oppenheim JJ, Chertov O & Lubkowski J (2000) The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J Biol Chem 275: 32911-32918.
20. Imamura Y, Fujigaki Y, Oomori Y, Ouryouji K, Yanagisawa S, Miyazawa H & Wang PL (2009) Transcriptional regulation of the salivary histatin gene: finding of a strong positive regulatory element and its binding protein. J Biochem 145: 279-288.
21. Johnson DA, Yeh CK & Dodds MWJ (2000) Effect of donor age on the concentrations of histatins in human parotid and submandibular/sublingual saliva. Arch Oral Biol 45: 731-740.
22. Jurevic RJ, Bai M, Chadwick RB, White TC & Dale BA (2003) Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol 41: 90-96.
23. Kolenbrander PE & London J (1993) Adhere today, here tomorrow: oral bacterial adherence. J Bacteriol 175: 3247-3252.
24. Kolenbrander PE, Andersen RN & Moore LV (1989) Coaggregation of Fusobacterium nucleatum, Selenomonas flueggei, Selenomonas infelix, Selenomonas noxia, and Selenomonas sputigena with strains from 11 genera of oral bacteria. Infect Immun 57: 3194-3203.
25. Krisanaprakornkit S, Weinberg A, Perez CN & Dale BA (1998) Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect Immun 66: 4222-4228.
26. Ledder RG & McBain AJ (2011) An in vitro comparison of dentifrice formulations in three distinct oral microbiotas. Arch Oral Biol [Epub ahead of print].
27. Ledder RG, Gilbert P, Huws SA, Aarons L, Ashley MP, Hull PS & McBain AJ (2007) Molecular analysis of the subgingival microbiota in health and disease. Appl Environ Microbiol 73: 516-523.
28. Ledder RG, Madhwani T, Sreenivasan PK, De Vizio W & McBain AJ (2009) An in vitro evaluation of hydrolytic enzymes as dental plaque control agents. J Med Microbiol 58: 482-491.
29. Ledder RG, Sreenivasan PK, DeVizio W & McBain AJ (2010) Evaluation of the specificity and effectiveness of selected oral hygiene actives in salivary biofilm microcosms. J Med Microbiol 59: 1462-1468.
30. Madhwani T & McBain A (2011) Bacteriological effects of a Lactobacillus reuteri probiotic on in vitro oral biofilms. Arch Oral Biol 56: 1264-1273.
31. Marsh P & Martin MV (1999) Oral Microbiology, 4th Ed. Wright, Oxford.
32. McBain AJ, Bartolo RG, Catrenich CE, Charbonneau D, Ledder RG & Gilbert P (2003) Growth and molecular characterization of dental plaque microcosms. J Appl Microbiol 94: 655-664.
33. Mosca DA, Hurst MA, So W, Viajar BSC, Fujii CA & Falla TJ (2000) IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis. Antimicrob Agents Chemother 44: 1803-1808.
34. Murakami Y, Nagata H, Amano A, Takagaki M, Shizukuishi S, Tsunemitsu A & Aimoto S (1991) Inhibitory effects of human salivary histatins and lysozyme on coaggregation between Porphyromonas gingivalis and Streptococcus mitis. Infect Immun 59: 3284-3286.
35. van Nieuw Amerongen A, Bolscher JGM & Veerman ECI (2004) Salivary proteins: protective and diagnostic value in cariology? Caries Res 38: 247-253.
36. Palmer RJ, Gordon SM, Cisar JO & Kolenbrander PE (2003) Coaggregation-mediated interactions of streptococci and actinomyces detected in initial human dental plaque. J Bacteriol 185: 3400-3409.
37. Perron GG, Zasloff M & Bell G (2006) Experimental evolution of resistance to an antimicrobial peptide. Proc Biol Sci 273: 251-256.
38. Pham LC, van Spanning RJM, Röling WFM et al. (2009) Effects of probiotic Lactobacillus salivarius W24 on the compositional stability of oral microbial communities. Arch Oral Biol 54: 132-137.
39. Selsted ME, Miller SI, Henschen AH & Ouellette AJ (1992) Enteric defensins: antibiotic peptide components of intestinal host defense. J Cell Biol 118: 929-936.
40. Selsted ME, Tang YQ, Morris WL et al. (1993) Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils. J Biol Chem 268: 6641-6648.
41. Steinberg DA, Hurst MA, Fujii CA et al. (1997) Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother 41: 1738-1742.
42. Tanaka D, Miyasaki KT & Lehrer RI (2000) Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium. Oral Microbiol Immunol 15: 226-231.
43. Tanida T, Okamoto T, Okamoto A, Wang H, Hamada T, Ueta E & Osaki T (2003) Decreased excretion of antimicrobial proteins and peptides in saliva of patients with oral candidiasis. J Oral Pathol Med 32: 586-594.
44. Tao R, Jurevic RJ, Coulton KK, Tsutsui MT, Roberts MC, Kimball JR, Wells N, Berndt J & Dale BA (2005) Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrob Agents Chemother 49: 3883-3888.
45. Territo MC, Ganz T, Selsted ME & Lehrer R (1989) Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest 84: 2017-2020.
46. Turkoglu O, Emingil G, Kutukculer N & Atilla G (2009) Gingival crevicular fluid levels of cathelicidin LL-37 and interleukin-18 in patients with chronic periodontitis. J Periodontol 80: 969-976.
47. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.